San Diego, CA, United States of America

Matthew J D'Onofrio

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 19(Granted Patents)


Location History:

  • Solana Beach, CA (US) (2022)
  • San Diego, CA (US) (2012 - 2023)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Matthew J D'Onofrio

Introduction

Matthew J D'Onofrio is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of nasal formulations. With a total of 7 patents to his name, D'Onofrio's work has the potential to impact the treatment of various medical conditions.

Latest Patents

One of D'Onofrio's latest patents focuses on nasal formulations of metoclopramide. These formulations are designed to remain stable and colorless during storage over time. The patent also outlines methods for treating disorders that can be addressed with metoclopramide, which involves administering these nasal solutions to patients in need.

Career Highlights

D'Onofrio is currently associated with Evoke Pharma, Inc., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to improving patient care through effective drug delivery systems.

Collaborations

Some of his notable coworkers include David A Gonyer and Shirish A Shah, who contribute to the collaborative environment at Evoke Pharma, Inc. Their combined expertise enhances the development of innovative solutions in the pharmaceutical industry.

Conclusion

Matthew J D'Onofrio's contributions to the field of pharmaceuticals, particularly through his patents on nasal formulations, demonstrate his dedication to advancing medical treatments. His work at Evoke Pharma, Inc. continues to pave the way for innovative healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…